Inaktiver Wert

Fresenius Kabi Oncology Ltd Aktie

Aktien

Schlusskurs NSE India S.E. Andere Börsenplätze
- ^INR	-

AstraZeneca sells rights to anaesthetics for up to $770 million	09.06.16
Fresenius SE KGaA : Kabi sells German oncology compounding business	16.02.15
Fresenius Kabi Oncology Ltd : India revokes GSK cancer drug patent in latest Big Pharma blow	02.08.13
Fresenius Kabi Oncology Ltd : India board revokes GSK patent on breast cancer drug Tykerb	02.08.13

Manager	Titel	Alter	Seit
Arvind Kumar Sharma CEO	Chief Executive Officer	-	01.07.18
Rahul Sharma DFI	Director of Finance/CFO	-	-
Maria Gobbi CHM	Chairman	-	13.11.14

Aufsichtsräte	Titel	Alter	Seit
Michael Schönhofen BRD	Director/Board Member	63	11.08.08
Nikhil Kulshreshtha BRD	Director/Board Member	-	21.07.07
Maria Gobbi CHM	Chairman	-	13.11.14

Sektor

	% 1. Jan.	Kap.
VERTEX PHARMACEUTICALS INCORPORATED	-1.43%	103 Mrd.
REGENERON PHARMACEUTICALS, INC.	+8.96%	101 Mrd.
ARGENX SE	+4.40%	23.07 Mrd.
BIONTECH SE	-12.15%	22.23 Mrd.
GENMAB A/S	-4.36%	18.05 Mrd.
WUXI APPTEC CO., LTD.	-39.98%	17.18 Mrd.
BEIGENE, LTD.	-10.04%	16.94 Mrd.
NEUROCRINE BIOSCIENCES, INC.	+6.79%	14.07 Mrd.
SAREPTA THERAPEUTICS, INC.	+38.61%	12.35 Mrd.